These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 37351170)
41. Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson's disease. Ay M; Charli A; Langley M; Jang A; Padhi P; Jin H; Anantharam V; Kalyanaraman B; Kanthasamy A; Kanthasamy AG Front Neurosci; 2024; 18():1356703. PubMed ID: 38449738 [TBL] [Abstract][Full Text] [Related]
43. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Büeler H Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005 [TBL] [Abstract][Full Text] [Related]
45. Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: Role of PINK-1/PARKIN and PI3K/Akt/CREB/BDNF/TrKB axis. Khidr HY; Hassan NF; Abdelrahman SS; El-Ansary MR; El-Yamany MF; Rabie MA Int Immunopharmacol; 2023 Dec; 125(Pt B):111207. PubMed ID: 37956489 [TBL] [Abstract][Full Text] [Related]
46. Alpha Lipoamide Ameliorates Motor Deficits and Mitochondrial Dynamics in the Parkinson's Disease Model Induced by 6-Hydroxydopamine. Zhou B; Wen M; Lin X; Chen YH; Gou Y; Li Y; Zhang Y; Li HW; Tang L Neurotox Res; 2018 May; 33(4):759-767. PubMed ID: 29019159 [TBL] [Abstract][Full Text] [Related]
47. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Cobb LJ; Lee C; Xiao J; Yen K; Wong RG; Nakamura HK; Mehta HH; Gao Q; Ashur C; Huffman DM; Wan J; Muzumdar R; Barzilai N; Cohen P Aging (Albany NY); 2016 Apr; 8(4):796-809. PubMed ID: 27070352 [TBL] [Abstract][Full Text] [Related]
48. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease. Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578 [TBL] [Abstract][Full Text] [Related]
49. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons. Kim GJ; Mo H; Liu H; Wu Z; Chen S; Zheng J; Zhao X; Nucum D; Shortland J; Peng L; Elepano M; Tang B; Olson S; Paras N; Li H; Renslo AR; Arkin MR; Huang B; Lu B; Sirota M; Guo S Elife; 2021 Sep; 10():. PubMed ID: 34550070 [TBL] [Abstract][Full Text] [Related]
50. Mechanisms of protection of retinal pigment epithelial cells from oxidant injury by humanin and other mitochondrial-derived peptides: Implications for age-related macular degeneration. Sreekumar PG; Kannan R Redox Biol; 2020 Oct; 37():101663. PubMed ID: 32768357 [TBL] [Abstract][Full Text] [Related]
51. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease. Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400 [TBL] [Abstract][Full Text] [Related]
52. Humanin: after the discovery. Niikura T; Chiba T; Aiso S; Matsuoka M; Nishimoto I Mol Neurobiol; 2004 Dec; 30(3):327-40. PubMed ID: 15655255 [TBL] [Abstract][Full Text] [Related]
53. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment. Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q Front Immunol; 2021; 12():794770. PubMed ID: 34925379 [TBL] [Abstract][Full Text] [Related]
54. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease. Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637 [TBL] [Abstract][Full Text] [Related]
55. Humanin antagonists: mutants that interfere with dimerization inhibit neuroprotection by Humanin. Hashimoto Y; Terashita K; Niikura T; Yamagishi Y; Ishizaka M; Kanekura K; Chiba T; Yamada M; Kita Y; Aiso S; Matsuoka M; Nishimoto I Eur J Neurosci; 2004 May; 19(9):2356-64. PubMed ID: 15128389 [TBL] [Abstract][Full Text] [Related]
56. Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6-OHDA model of Parkinson's disease. Iravanpour F; Dargahi L; Rezaei M; Haghani M; Heidari R; Valian N; Ahmadiani A CNS Neurosci Ther; 2021 Mar; 27(3):308-319. PubMed ID: 33497031 [TBL] [Abstract][Full Text] [Related]
57. Reduced skeletal muscle expression of mitochondrial-derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease. Liu C; Gidlund EK; Witasp A; Qureshi AR; Söderberg M; Thorell A; Nader GA; Barany P; Stenvinkel P; von Walden F Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1122-F1131. PubMed ID: 31432706 [TBL] [Abstract][Full Text] [Related]
58. Protective Effect of Tocotrienol on In Vitro and In Vivo Models of Parkinson's Disease. Matsura T J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S51-S53. PubMed ID: 31619646 [TBL] [Abstract][Full Text] [Related]
59. A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice. Niikura T; Sidahmed E; Hirata-Fukae C; Aisen PS; Matsuoka Y PLoS One; 2011 Jan; 6(1):e16259. PubMed ID: 21264226 [TBL] [Abstract][Full Text] [Related]
60. [Humanin and its derivatives as peptides with potential antiapoptotic and confirmed neuroprotective activities]. Zapała B; Staszel T; Kieć-Wilk B; Polus A; Knapp A; Wybrańska I; Kaczyński Ł; Dembińska-Kieć A Przegl Lek; 2011; 68(7):372-7. PubMed ID: 22010475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]